Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis

A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis

(2018) Scott L. Friedman et al.   HEPATOLOGY

Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers

(2018) Eduardo Vilar-Gomez et al.   JOURNAL OF HEPATOLOGY

The FDA/critical path initiative/Duke-Margolis center for health policy public workshop on analytical validation of assays for biomarker qualification: an update on the White Paper

(2018) Steven P Piccoli   Bioanalysis

Putting non-alcoholic fatty liver disease on the radar for primary care physicians: how well are we doing?

(2018) Arun J. Sanyal   BMC Medicine

Rifaximin in nonalcoholic fatty liver disease

(2018) Ahmed Abdel-Razik et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Current Concepts in Pediatric Nonalcoholic Fatty Liver Disease

(2017) Sarah E. Fleet et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

(2017) Chris Estes et al.   HEPATOLOGY

Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease

(2017) S Lefere et al.   INTERNATIONAL JOURNAL OF OBESITY

A simple scoring system using type IV collagen 7S and aspartate aminotransferase for diagnosing nonalcoholic steatohepatitis and related fibrosis

(2017) Takeshi Okanoue et al.   JOURNAL OF GASTROENTEROLOGY

P-selectin, endocan, and some adhesion molecules in obese children and adolescents with non-alcoholic fatty liver disease

(2017) Ala Ustyol et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease

(2016) Veeral Ajmera et al.   HEPATOLOGY

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH)

(2016) Marina Nati et al.   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Inflammatory Markers Change with Age, but do not Fall Beyond Reported Normal Ranges

(2015) Aleksandra Wyczalkowska-Tomasik et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Biomarker Qualification: Toward a Multiple Stakeholder Framework for Biomarker Development, Regulatory Acceptance, and Utilization

(2015) S Amur et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States

(2015) Robert J. Wong et al.   GASTROENTEROLOGY

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2015) Paul Angulo et al.   GASTROENTEROLOGY

Identification of novel noninvasive markers for diagnosing nonalcoholic steatohepatitis and related fibrosis by data mining

(2015) Keito Yoshimura et al.   HEPATOLOGY

Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease

(2015) Sanja Stojsavljević   WORLD JOURNAL OF GASTROENTEROLOGY

Carotid Intima-Media Thickness Is Predicted by Combined Eotaxin Levels and Severity of Hepatic Steatosis at Ultrasonography in Obese Patients with Nonalcoholic Fatty Liver Disease

(2014) Giovanni Tarantino et al.   PLoS One

Knowledge-Based Identification of Soluble Biomarkers: Hepatic Fibrosis in NAFLD as an Example

(2013) Sandra Page et al.   PLoS One

Nonalcoholic Fatty Liver Disease

(2012) Angelo H. Paredes et al.   Clinics in Liver Disease

C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients

(2011) Esther Zimmermann et al.   JOURNAL OF HEPATOLOGY

Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings

(2010) Elizabeth M. Brunt et al.   HEPATOLOGY

Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2009) Amy G. Shah et al.   Clinical Gastroenterology and Hepatology

Genetic polymorphisms in non-alcoholic fatty liver disease: Interleukin-6−174G/C polymorphism is associated with non-alcoholic steatohepatitis

(2009) L. Carulli et al.   DIGESTIVE AND LIVER DISEASE

Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis

(2008) Anna Wieckowska et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY